NCT07163260View on ClinicalTrials.gov

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

Enrolling by invitationOBSERVATIONAL
Enrollment

244

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Haemophilia
Interventions
OTHER

No treatment given

No treatment given

Trial Locations (4)

10500

Novo Nordisk Investigational Site, Bangkok

50470

Novo Nordisk Investigational Site, Kuala Lumpur

560 066

Novo Nordisk Investigational Site, Bangalore

Unknown

Novo Nordisk Investigational Site, Seoul

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT07163260 - Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia | Biotech Hunter | Biotech Hunter